Fatty liver disease

The background

There is a recent publication: The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study

The publication is available via NIH.

The challenge

Within the publication the below plots were present. This months challenge is to improve a plot or find a better way to visually present the data.

Mean Change in LSM values (kPa). Comparisons between the groups were performed using unpaired t-tests. Data were collected after six months of randomization.

Comparison of Overall Improvement in Steatosis at the end of study.

The data

The data is derived to match the plotted results in the publication.

Variable Name	Variable Label
Group	Treatment group
Baseline_kPa	Baseline value of the LSM Score
EOS_kPa	End of study value of the LSM Score
Sex	Sex (male/female)
Steatosis	Course of steatosis
Age	Age at baseline in years
Weight	Baseline weight in kg